Ggayi Abu-Baker Mustapher

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.

D. Watson-Jones, P. Kaleebu, O. Anzala, 2023, Vaccine.

Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda

P. Kaleebu, L. Nyakarahuka, J. Lutwama, 2024, Virology Journal.